Matthew Pink
Vice President, Business Development Biodesix
Seminars
Thursday 5th February 2026
Proteomics as a Catalyst for Next-Gen Therapeutics: Leveraging Mass Spectrometry & MALDI-IHC to Accelerate TPD, ADC, & ASO Clinical Development
11:25 am
